Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

734.97 -20.94 (-2.77%)
Official Closing Price Updated: 7:00 PM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,595,193
Open 743.00
Bid (Size) 735.00 (1)
Ask (Size) 740.40 (1)
Prev. Close 755.91
Today's Range 730.34 - 745.00
52wk Range 423.00 - 800.78
Shares Outstanding N/A
Dividend Yield 0.61%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Amgen Stock Zoomed Nearly 12% Higher Today
The company delivered solid quarterly results, but its discussion of an investigational drug is what really gave its shares a pop. 
Via The Motley Fool
3 Under-The-Radar Stocks That Could Be Worth Over $1 Trillion by 2030
These under-the-radar stocks have the potential to reach a $1 trillion valuation by 2030 as they gain momentum in their respective industries. 
Via InvestorPlace

Performance

YTD
+24.11%
+24.11%
1 Month
-5.29%
-5.29%
3 Month
+10.08%
+10.08%
6 Month
+29.44%
+29.44%
1 Year
+71.55%
+71.55%

More News

Read More
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Stock Market Rallies On Fed, Jobs Report, Apple: Weekly Review
Via Investor's Business Daily
Topics Economy
Exposures Interest Rates
Comparative Study: Eli Lilly and Co And Industry Competitors In Pharmaceuticals Industry
Via Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly and Co
Via Benzinga
Here's Why Eli Lilly Stock Remains a Screaming Buy
Via The Motley Fool
Wage Growth Slows – Stock Market Celebrates, Five Real Reasons Apple Is Running Up
Via Benzinga
1 Wall Street Analyst Thinks Eli Lilly Stock Is Going to $892. Is It a Buy?
Via The Motley Fool
Weigh Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
Via Benzinga
3 Stocks Gunning for Trillion-Dollar Status: The Players to Own Now
Via InvestorPlace
What 23 Analyst Ratings Have To Say About Eli Lilly and Co
Via Benzinga
3 Staples Stocks to Cushion Lower Consumer Sentiment
Via MarketBeat
Topics Economy
Exposures Economy
Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition
Via Benzinga
Q1 Earnings Seasons Picks & Pans: The 4 Biggest Stock Winners (and 3 Losers)
Via InvestorPlace
Eli Lilly 'On Its Way' To $1 Trillion Market Cap, Analysts Say: It's A 'Have' In A Sea Of 'Have Nots'
Via Benzinga
ETFs To Buy As Eli Lilly Beats Q1 Earnings, Lifts Outlook
Via Talk Markets
Topics ETFs
Profit from the Panic: 3 Stocks to Pounce on When They Become Steals
Via InvestorPlace
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Consumer Stocks.
Via InvestorPlace
Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge
Via InvestorPlace
3 Healthcare Stocks With the Potential to Triple Your Investment by 2026
Via InvestorPlace
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To Perform Consistently With Expectations
Via Benzinga
Exposures COVID-19
Nearly 50% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 4 Stocks
Via The Motley Fool
How Consumer Demand Is Impacting Taiwan Semiconductor Manufacturing Co.
Via The Motley Fool
These 3 Companies Recently Lifted Guidance
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.